135 related articles for article (PubMed ID: 30735823)
1. Investigating molecular interactions of high-loaded glipizide-HPMCAS microparticles by integrated experimental and modeling techniques.
Li Q; Zhao Q; Jing Q; Ma X; Chen N; Ren G; Ouyang D; Ren F
Eur J Pharm Sci; 2019 Apr; 131():127-135. PubMed ID: 30735823
[TBL] [Abstract][Full Text] [Related]
2. Multiscale Computational Modeling of the Nanostructure of Solid Dispersions of Hydroxypropyl Methylcellulose Acetate Succinate (HPMCAS) and Phenytoin.
Huang W; Mandal T; Larson RG
Mol Pharm; 2017 Oct; 14(10):3422-3435. PubMed ID: 28829134
[TBL] [Abstract][Full Text] [Related]
3. Supersaturated controlled release matrix using amorphous dispersions of glipizide.
Lu Z; Yang Y; Covington RA; Bi YV; Dürig T; Ilies MA; Fassihi R
Int J Pharm; 2016 Sep; 511(2):957-68. PubMed ID: 27492020
[TBL] [Abstract][Full Text] [Related]
4. Miniaturized Measurement of Drug-Polymer Interactions via Viscosity Increase for Polymer Selection in Amorphous Solid Dispersions.
Auch C; Harms M; Golitsyn Y; Reichert D; Mäder K
Mol Pharm; 2019 May; 16(5):2214-2225. PubMed ID: 30920843
[TBL] [Abstract][Full Text] [Related]
5. Physical properties and solubility studies of Nifedipine-PEG 1450/HPMCAS-HF solid dispersions.
Haware RV; Vinjamuri BP; Gavireddi M; Dave VS; Gupta D; Chougule MB; Stagner WC
Pharm Dev Technol; 2019 Jun; 24(5):550-559. PubMed ID: 30175691
[TBL] [Abstract][Full Text] [Related]
6. Molecular dynamics simulation of amorphous hydroxypropyl-methylcellulose acetate succinate (HPMCAS): polymer model development, water distribution, and plasticization.
Xiang TX; Anderson BD
Mol Pharm; 2014 Jul; 11(7):2400-11. PubMed ID: 24871211
[TBL] [Abstract][Full Text] [Related]
7. In vitro characterization of a novel polymeric system for preparation of amorphous solid drug dispersions.
Mahmoudi ZN; Upadhye SB; Ferrizzi D; Rajabi-Siahboomi AR
AAPS J; 2014 Jul; 16(4):685-97. PubMed ID: 24789531
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of griseofulvin binary and ternary solid dispersions with HPMCAS.
Al-Obaidi H; Buckton G
AAPS PharmSciTech; 2009; 10(4):1172-7. PubMed ID: 19842041
[TBL] [Abstract][Full Text] [Related]
9. Crystallization of amorphous solid dispersions of resveratrol during preparation and storage-Impact of different polymers.
Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
J Pharm Sci; 2013 Jan; 102(1):171-84. PubMed ID: 23132686
[TBL] [Abstract][Full Text] [Related]
10. Computational Modeling of Hydroxypropyl-Methylcellulose Acetate Succinate (HPMCAS) and Phenytoin Interactions: A Systematic Coarse-Graining Approach.
Huang W; Mandal T; Larson RG
Mol Pharm; 2017 Mar; 14(3):733-745. PubMed ID: 28142242
[TBL] [Abstract][Full Text] [Related]
11. Mechanism-based selection of stabilization strategy for amorphous formulations: Insights into crystallization pathways.
Edueng K; Mahlin D; Larsson P; Bergström CAS
J Control Release; 2017 Jun; 256():193-202. PubMed ID: 28412224
[TBL] [Abstract][Full Text] [Related]
12. Utility of Films to Anticipate Effect of Drug Load and Polymer on Dissolution Performance from Tablets of Amorphous Itraconazole Spray-Dried Dispersions.
Honick M; Sarpal K; Alayoubi A; Zidan A; Hoag SW; Hollenbeck RG; Munson EJ; Polli JE
AAPS PharmSciTech; 2019 Nov; 20(8):331. PubMed ID: 31677012
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions.
McNamara D; Yin S; Pan D; Crull G; Timmins P; Vig B
Mol Pharm; 2017 Feb; 14(2):377-385. PubMed ID: 28068097
[TBL] [Abstract][Full Text] [Related]
14. Influence of beta-cyclodextrin complexation on glipizide release from hydroxypropyl methylcellulose matrix tablets.
Shivakumar HN; Desai BG; Pandya S; Karki SS
PDA J Pharm Sci Technol; 2007; 61(6):472-91. PubMed ID: 18410048
[TBL] [Abstract][Full Text] [Related]
15. Stability-enhanced hot-melt extruded amorphous solid dispersions via combinations of Soluplus® and HPMCAS-HF.
Alshahrani SM; Lu W; Park JB; Morott JT; Alsulays BB; Majumdar S; Langley N; Kolter K; Gryczke A; Repka MA
AAPS PharmSciTech; 2015 Aug; 16(4):824-34. PubMed ID: 25567525
[TBL] [Abstract][Full Text] [Related]
16. Effect of HPMCAS on recrystallization inhibition of nimodipine solid dispersions prepared by hot-melt extrusion and dissolution enhancement of nimodipine tablets.
Zhang Q; Zhao Y; Zhao Y; Ding Z; Fan Z; Zhang H; Liu M; Wang Z; Han J
Colloids Surf B Biointerfaces; 2018 Dec; 172():118-126. PubMed ID: 30144623
[TBL] [Abstract][Full Text] [Related]
17. Effect of drug-polymer interactions on the aqueous solubility of milled solid dispersions.
Al-Obaidi H; Lawrence MJ; Shah S; Moghul H; Al-Saden N; Bari F
Int J Pharm; 2013 Mar; 446(1-2):100-5. PubMed ID: 23410988
[TBL] [Abstract][Full Text] [Related]
18. The role of drug-polymer hydrogen bonding interactions on the molecular mobility and physical stability of nifedipine solid dispersions.
Kothari K; Ragoonanan V; Suryanarayanan R
Mol Pharm; 2015 Jan; 12(1):162-70. PubMed ID: 25426538
[TBL] [Abstract][Full Text] [Related]
19. The effect of HPMCAS functional groups on drug crystallization from the supersaturated state and dissolution improvement.
Ueda K; Higashi K; Yamamoto K; Moribe K
Int J Pharm; 2014 Apr; 464(1-2):205-13. PubMed ID: 24440403
[TBL] [Abstract][Full Text] [Related]
20. Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution.
Purohit HS; Taylor LS
Pharm Res; 2017 Dec; 34(12):2842-2861. PubMed ID: 28956218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
